English | Español
Robert Hadley | Jun 19, 2017

U.S. clinical trial for chikungunya virus vaccine to begin
Carol Ostrow | Jun 18, 2017

UW, Seattle genomics center researchers identify disease proteins
Robert Hadley | Jun 18, 2017

Study may lead to development of Lassa vaccine
Ruth de Jauregui | Jun 17, 2017

Bristol-Myers Squibb, Calithera Biosciences to evaluate Opdivo, CB-839 in treating non-small cell lung cancer
Robert Hadley | Jun 17, 2017

U.S. court sides with Horizon Pharma in patent infringement claim regarding Pennsaid
Cheyenne Dickerson | Jun 16, 2017

American Cancer Society posts 6 steps to help survivors live longer lives

Robert Hadley | Jun 16, 2017

Calithera says trials indicate new drug can inhibit growth of solid tumors
Robert Hadley | Jun 16, 2017

Merck’s Keytruda shown effective in treating aggressive form of breast cancer

Trending
Patient Daily | Aug 4, 2025

Founder of ReKlaim Health on 340B: ‘They pocket the difference, bill insurers and patients full price and call it charity care’
+ Pharmaceuticals
Patient Daily | Aug 8, 2025

PhRMA Chief Public Affairs Officer on 340B abuse: ‘Big, tax-exempt hospitals in urban areas are using a loophole to qualify as “rural”’
Patient Daily | Aug 1, 2025

Executive director of ASAP 340B: ‘The second largest drug discount program in the country doesn't have basic transparency’
+ Pharmaceuticals
Patient Daily | Aug 5, 2025

American Lung Association study urges schools to prioritize clean classroom air